United States-based Johnson & Johnson has proposed a sweeping, multibillion-dollar settlement framework aimed at resolving tens of thousands of lawsuits alleging that its talc-based products caused ovarian cancer. The healthcare company has faced these claims for more than a decade, during which the litigation has weighed on its reputation, influenced its financial planning and shaped its operational focus. The proposed resolution seeks to address a large volume of cases in a single, comprehensive structure, reflecting the scale of the legal challenge and the company’s effort to bring long-running disputes over its iconic talc products to an end. United States courts have become a central arena for these mass tort claims, which have raised broader questions about consumer safety and corporate accountability in the modern marketplace. Johnson & Johnson continues to maintain that its talc products are safe and free from harmful contaminants, but is pursuing this global framework to obtain definitive closure on the litigation. The proposal requires substantial claimant support and multiple layers of legal approval before it can take effect, and its implementation would mark a significant turning point in how large corporations manage systemic legal crises and structure future risk-management strategies.

Prepared by Christopher Adams and reviewed by editorial team.